Literature DB >> 12707006

An unraveling tale of how integrins are activated from within.

Mark A Travis1, Jonathan D Humphries, Martin J Humphries.   

Abstract

Integrin cytoplasmic tail domains are short, but are essential for normal receptor function because of their key role in relaying bidirectional signals across the plasma membrane. Although it is well established that the cytoplasmic tails both initiate signalling pathways inside the cell and control the transition of integrins from a resting to a ligand-binding competent state, until recently the structural basis of these changes has been unclear. In the past year, however, a series of structural studies has revealed certain features of cytoplasmic domain function, and in this review we focus on how these advances have enlightened our understanding of integrin tail structure and function.

Mesh:

Substances:

Year:  2003        PMID: 12707006     DOI: 10.1016/S0165-6147(03)00069-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  13 in total

1.  Novel activating and inactivating mutations in the integrin beta1 subunit A domain.

Authors:  Stephanie J Barton; Mark A Travis; Janet A Askari; Patrick A Buckley; Susan E Craig; Martin J Humphries; A Paul Mould
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

2.  Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine.

Authors:  Elisha Waldman; Sydney X Lu; Vanessa M Hubbard; Adam A Kochman; Jeffrey M Eng; Theis H Terwey; Stephanie J Muriglan; Theo D Kim; Glenn Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

Review 3.  Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance.

Authors:  Hassan Yousefi; Mousa Vatanmakanian; Mojdeh Mahdiannasser; Ladan Mashouri; Nikhilesh V Alahari; Mohammad Rafiee Monjezi; Shahrzad Ilbeigi; Suresh K Alahari
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

4.  Dual functionality of the anti-beta1 integrin antibody, 12G10, exemplifies agonistic signalling from the ligand binding pocket of integrin adhesion receptors.

Authors:  Jonathan D Humphries; Neil R Schofield; Zohreh Mostafavi-Pour; Linda J Green; Alistair N Garratt; A Paul Mould; Martin J Humphries
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

5.  Dynamic regulation of fibrinogen: integrin αIIbβ3 binding.

Authors:  Roy R Hantgan; Mary C Stahle; Susan T Lord
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

6.  Evidence that monoclonal antibodies directed against the integrin beta subunit plexin/semaphorin/integrin domain stimulate function by inducing receptor extension.

Authors:  A Paul Mould; Mark A Travis; Stephanie J Barton; Jennifer A Hamilton; Janet A Askari; Susan E Craig; Philip R Macdonald; Richard A Kammerer; Patrick A Buckley; Martin J Humphries
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

7.  Reconstructing integrin activation in vitro.

Authors:  Alexandre R Gingras; Feng Ye; Mark H Ginsberg
Journal:  Methods Mol Biol       Date:  2013

8.  Del-1 gene transfer induces cerebral angiogenesis in mice.

Authors:  Yongfeng Fan; Wei Zhu; Michael Yang; Yiqian Zhu; Fanxia Shen; Qi Hao; William L Young; Guo-Yuan Yang; Yongmei Chen
Journal:  Brain Res       Date:  2008-05-10       Impact factor: 3.252

9.  Transmembrane helices that form two opposite homodimeric interactions: an asparagine scan study of alphaM and beta2 integrins.

Authors:  Krupakar Parthasarathy; Xin Lin; Suet Mien Tan; S K Alex Law; Jaume Torres
Journal:  Protein Sci       Date:  2008-03-27       Impact factor: 6.725

10.  The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy.

Authors:  Xinjie Lu; Dong Lu; Mike Scully; Vijay Kakkar
Journal:  Perspect Medicin Chem       Date:  2008-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.